Picture of Eris Lifesciences logo

ERIS — Eris Lifesciences News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

India's Eris Lifesciences shares rise in debut after $264 mln IPO

June 29 (Reuters) - Indian drugmaker Eris Lifesciences Ltd's 
 ERIS.NS  shares rose as much as 4.2 percent on their trading 
debut on Thursday, after its initial public offering raised 17 
billion rupees ($263.8 million). 
    The shares were up 1.2 percent at 610.45 rupees by 0434 GMT 
on the National Stock Exchange, compared with their IPO price of 
603 rupees. 
    The IPO was subscribed more than three times on the last day 
of the sale on June 20.  urn:newsml:reuters.com:*:nL3N1JH43U 
 
($1 = 64.4400 Indian rupees) 
 
 (Reporting by Jessica Kuruthukulangara in Bengaluru; Editing by 
Amrutha Gayathri) 
 ((Jessica.Kuruthukulangara@thomsonreuters.com; outside U.S.: 
+91-80-6749-7142; Reuters Messaging: 
Jessica.Kuruthukulangara.reuters.com@reuters.net)) 
 
Keywords: ERIS LIFE LISTING/

Recent news on Eris Lifesciences

See all news